Clinical benefits of miglustat on bone disease in adult type 1 Gaucher disease (GD1): A meta-analysis

被引：0
|
作者：
Pastores, G. M.
Elstein, D.
Hrebicek, M.
Zimran, A.
机构：
[1] NYU, Sch Med, Dept Neurol & Pediat, New York, NY USA
[2] Shaare Zedek Med Ctr, Dept Med, IL-91000 Jerusalem, Israel
[3] Inst IMD, Prague, Czech Republic
来源：
CALCIFIED TISSUE INTERNATIONAL | 2007年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [31] Long term efficacy and safety of miglustat therapy in type 1 Gaucher disease
    Giraldo, M.
    Latre, P.
    Acedo, A.
    Alonso, D.
    Barez, A.
    Martin, A.
    Franco, R.
    Fernandez-Villamor, A.
    Pocovi, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 279 - 279
  • [32] Miglustat therapy in type 1 Gaucher disease: Clinical and safety outcomes in a multicenter retrospective cohort study
    Kuter, David J.
    Mehta, Atul
    Hollak, Carla E. M.
    Giraldo, Pilar
    Hughes, Derralynn
    Belmatoug, Nadia
    Brand, Monika
    Muller, Audrey
    Schaaf, Berthold
    Giorgino, Ruben
    Zimran, Ari
    BLOOD CELLS MOLECULES AND DISEASES, 2013, 51 (02) : 116 - 124
  • [33] Bone density in Type 1 Gaucher disease
    Pastores, GM
    Wallenstein, S
    Desnick, RJ
    Luckey, MM
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (11) : 1801 - 1807
  • [34] Type 1 Gaucher disease:: Clinical interest of bone scan.
    Harel, F
    Belmatoug, N
    Lebtahi, R
    Hitzel, A
    Génin, R
    Daou, D
    Ghazzar, N
    Faraggi, M
    Le Guludec, D
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 338P - 338P
  • [35] Oral maintenance with miglustat in adult patients with type 1 Gaucher disease: The patients quality-of-life perspective
    Elstein, D.
    Dweck, A.
    Attias, D.
    Hadas-Halpern, I
    Zevin, S.
    Altarescu, G.
    Zimran, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 120 - 120
  • [36] ELIGLUSTAT TARTRATE, AN INVESTIGATIONAL ORAL THERAPY FOR GAUCHER DISEASE TYPE 1 (GD1): PHASE 2 RESULTS AFTER 2 YEARS
    Lukina, E.
    Peterschmitt, J.
    Watman, N.
    Arreguin, E. A.
    Pastores, G.
    Lastrebner, M.
    Dragosky, M.
    Rosenbaum, H.
    Phillips, M.
    Kaper, M.
    Singh, T.
    Puga, A. C.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S147 - S147
  • [37] A Comprehensive Study of Bone Manifestations in Adult Patients with Gaucher Disease type 1
    Oliveri, Beatriz
    Gonzalez, Diana
    Quiroga, Felisa
    Silva, Claudio
    Rozenfeld, Paula
    Lis, Camilo
    Riemersma, Omar
    Kot, Martin
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 299 - 299
  • [38] Substrate reduction therapy with miglustat for type 1 Gaucher disease: A retrospective analysis from a single institution
    Machaczka, Maciej
    Hast, Robert
    Dahlman, Ingrid
    Lerner, Richard
    Klimkowska, Monika
    Engvall, Martin
    Hagglund, Hans
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2012, 117 (01) : 28 - 34
  • [39] Role of oxidative stress and inflammation in type 1 Gaucher disease (GD1): Potential use of antioxidant/anti-inflammatory medications
    Kartha, Reena V.
    Joers, James
    Tuite, Paul
    Hovde, Laurie B.
    Mishra, Usha
    Rudser, Kyle
    Oz, Gulin
    Utz, Jeanine James
    Cloyd, James C.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S74 - S74
  • [40] Eliglustat for Gaucher disease Type 1 (GD1): Safety results from a Phase 2 study after 2 years of treatment
    Peterschmitt, M. Judith
    Lukina, Elena
    Watman, Nora
    Dragosky, Marta
    Iastrebner, Marcelo
    Pastores, Gregory
    Avila Arreguin, Elsa
    Rosenbaum, Hanna
    Phillips, Mici
    Kaper, Mathilde
    Bertin-Millet, Dominique
    Puga, Ana Cristina
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S35 - S35
12345